COVID- Regeneron

Regeneron says its Covid-19 antibody treatment cut medical visits in trial

Regeneron Pharmaceuticals said Wednesday its coronavirus antibody cocktail, the experimental treatment that President Donald Trump received, significantly reduced medical visits in a trial of nearly 800 patients with mild-to-moderate Covid-19.Regeneron said patients given the treatment, REGN-COV2, made around 57 percent fewer Covid-19-related medical visits than those given a placebo over a 29-day period.The drop was…

Australia’s COVID-

Australia’s COVID hotspot state records two days without new cases for first time in seven months

SYDNEY — The Australian state of Victoria, the epicenter of COVID-19 infections, said on Tuesday it had gone 48 hours without detecting any new cases for the first time in more than seven months.Victoria, the second most populous state, will allow restaurants and cafes in Melbourne to reopen from Wednesday after more than three months…

COVID- Thromboembolic

COVID-19: Thromboembolic Events High Despite Prophylaxis

Major thromboembolic complications and adverse cardiovascular events occurred with high frequency in patients with COVID-19, especially in the intensive care setting, despite a high use of thromboprophylaxis, in a new large observational US study. “Despite very high rate of antithrombotic prophylaxis there were a high rate of thromboembolic events suggesting that we are probably not…

COVID- Higher

Higher COVID Death Risk Spelled Out by Troponins, ECG

Hospitalized patients with COVID-19 and myocardial injury had a broad range of echocardiographic abnormalities that put them at higher risk of in-hospital mortality, according to registry data from spring 2020. Among 305 patients with lab-confirmed SARS-CoV-2 infection who underwent transthoracic echocardiography (TTE) and ECG evaluation, 62.6% had troponin elevations suggestive of myocardial injury (either at…

COVID- Latest

Latest COVID-19 business exposures, as of Oct. 26

The SHA warned of potential COVID-19 exposures in Regina, Indian Head, Esterhazy, Estevan, Lloydminster, Prince Albert, Saskatoon and Shellbrook.Author of the article:Regina Leader-PostPublishing date:Oct 26, 2020  •   •  2 minute readThis handout file illustration image obtained February 27, 2020 courtesy of the Centers for Disease Control and Prevention and created at the Centers for Disease…

catch COVID-

You can still catch COVID-19 in this place that experts are calling safe

A new study that analyzes the risk of coronavirus transmission on commercial airplane flights should offer a dose of good news to travelers eager to take to the skies again. The US Department of Defense report finds that the risk of COVID-19 exposure during a flight is highly unlikely — not impossible, but very rare.…

COVID- Vaccine

COVID-19 Vaccine Standards Questioned at FDA Advisory Meeting

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Federal advisers, researchers, and several medical groups on Thursday suggested changes to the US Food and Drug Administration’s (FDA) current plans for deciding how to eventually clear vaccines for COVID-19, arguing tougher standards would help bolster confidence in these critical medicines.…

COVID- Third

Third COVID case reported at Tecumseth Beeton ES

A third case of COVID-19 at Tecumseth Beeton Elementary School has been reported by the Simcoe County District School Board. No classrooms have been closed as a result of the new case. The board has not identified whether the individual is a student or staff member. In a letter to parents and guardians sent out…

confirmed COVID-

COVID case confirmed at Guthrie school

A single case of COVID-19 has been confirmed at Guthrie Public School in Oro-Medonte Township.  No classrooms have been closed and the Line 5 school remains open.  No information has been released about whether the case involves a student or a staff member. Due to privacy legislation, the health unit does not release personal or identifying information…

COVID- Plans

UK Plans COVID-19 ‘Challenge’ Trials That Deliberately Infect Volunteers

LONDON (Reuters) – Britain will help to fund trials using a manufactured COVID-19 virus to deliberately infect young healthy volunteers with the hope of accelerating the development of vaccines against it. The government said on Tuesday it will invest 33.6 million pounds ($43.5 million) in the so-called human challenge trials in partnership with Imperial College…